National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$42.00
add to cart

Rights & Permissions

topleft topright

Strategies to Leverage Research Funding: Guiding DOD's Peer Reviewed Medical Research Programs (2004)
Medical Follow-Up Agency (MFUA)
Board on Health Sciences Policy (HSP)

Citation Manager

. "2 Sources of Funding for Biomedical Research." Strategies to Leverage Research Funding: Guiding DOD's Peer Reviewed Medical Research Programs. Washington, DC: The National Academies Press, 2004.

Please select a format:

BibTeX EndNote RefMan


Page
54
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Strategies to Leverage Research Funding: Guiding Dod’s Peer Reviewed Medical Research Programs

NSF. 2003b. Academic Research and Development Expenditures: Fiscal Year 2001. NSF 03-316. Arlington, VA: NSF. [On-line.] Available: www.nsf.gov/sbe/srs/nsf03316/start.htm [accessed July 18, 2004].

NSF. 2004a. Science and Engineering Indicators 2004. Two volumes: volume 1, NSB 04-1; volume 2, NSB 04-1A. Arlington, VA: National Science Board, NSF. [On-line.] Available: www.nsf.gov/sbe/srs/seind04/start.htm [accessed July 18, 2004].

NSF. 2004b. U.S. Academic R&D Continues to Grow as More Universities and Colleges Expand Their R&D Activities (NSF InfoBrief). NSF 04-319. Arlington, VA: NSF. [On-line.] Available: www.nsf.gov/sbe/srs/infbrief/nsf04319/start.htm [accessed July 18, 2004].

NVCA (National Venture Capital Association). 2004a. What Is Venture Capital? [Online.] Available: www.nvca.org/def.html [accessed July 12, 2004].

NVCA. 2004b. Venture Capital Stays the Course in Q1 2004 with $4.6 billion Invested (Press Release). [Online.] Available: www.nvca.org/pdf/Q104MTReleaseEmbargoFINAL.pdf [accessed July 12, 2004].


PhRMA (Pharmaceutical Research and Manufacturers of America). 1997. New Medicines in Development for Cancer: 1997 Survey. Washington, DC: PhRMA.

PhRMA. 2003. Medicines in Development for Cancer: 2003 Survey. Washington, DC: PhRMA, May. [On-line.] Available: www.phrma.org/newmedicines/resources/2003-05-12.109.pdf [accessed May 20, 2004].

PhRMA. 2004. Pharmaceutical Industry Profile 2004. Washington, DC: PhRMA. [On-line.] Available: www.phrma.org/publications/publications//2004-03-31.937.pdf [accessed May 20, 2004].


R!A (Research!America). 2003. 2001 Investment in U.S. Health Research [Issue Paper]. Alexandria, VA: R!A. Data supplied by Stacie Propst, Ph.D.

R!A. 2004. 2002 Investment in U.S. Health Research [Issue Paper]. Alexandria, VA: R!A. [On-line.] Available: www.researchamerica.org/publications/appropriations/healthdollar2002.pdf [accessed July 18 2004].


U.S. GAO (U.S. General Accounting Office). 2004. Tobacco Settlement: States’ Allocations of Fiscal Year 2003 and Expected Fiscal Year 2004 Payments. GAO-04-518. Washington, DC: GAO. [On-line.] Available: www.gao.gov/new.items/d04518.pdf [accessed July 18, 2004].

Page
54